BNP in HIV-infected patients;Wertigkeit des Biomarkers BNP bei HIV-infizierten Patienten

Herz

Volumn 34, Issue 8, 2009, Pages 634-640

  Neumann, Till ^a   Reinsch, Nico ^a   Neuhaus, Kathrin ^a   Brockmeyer, Norbert ^b   Potthoff, Anja ^b   Esser, Stefan ^a   Hower, Martin ^c   Neumann, Anja ^d   Mostardt, Sarah ^d   Gelbrich, Götz ^e   Erbel, Raimund ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c Klinikum   (Germany)

^d UNIVERSITY OF DUISBURG ESSEN   (Germany)

^e UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Antiretroviral therapy; Biomarker; BNP; HIV infection

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BRAIN NATRIURETIC PEPTIDE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AGE DISTRIBUTION; ARTICLE; BRAIN NATRIURETIC PEPTIDE BLOOD LEVEL; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART FAILURE; HEART RIGHT VENTRICLE; HEART VENTRICLE SIZE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MULTICENTER STUDY; OUTPATIENT; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEX RATIO;

ADULT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COHORT STUDIES; COMORBIDITY; FEMALE; GERMANY; HIV INFECTIONS; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 73649140270     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-009-3313-7     Document Type: Article

References (19)

1. M. Lainscak S.D. Anker 2009 Prognostic factors in chronic heart failure. A review of serum biomarkers, metabolic changes, symptoms, and scoring systems Herz 34 141 147 10.1007/s00059-009-3211-z 19370331
2. T. Neumann 2008 HIV, AIDS and the cardiovascular risk Internist (Berl) 49 432 435 10.1007/s00108-008-2049-4
3. T. Neumann J. Kondratieva F. Breuckmann, et al. 2005 HIV-associated cardiomyopathy Herz 30 545 549 10.1007/s00059-005-2729-y 16170687 (Pubitemid 41367147)
4. Fisher SD, Lipshultz SE. Cardiovascular abnormalities in HIV-infected individuals. In: Braunwald E, ed. Heart disease: a text book of cardiovascular medicine. Philadelphia: Saunders, 2001:2211-2221.
5. A.J. Jacob N.A. Boon 1991 HIV cardiomyopathy: a dark cloud with a silver lining? Br Heart J 66 1 2 10.1136/hrt.66.1.1 1:STN:280:DyaK3MzgslylsQ%3D%3D 1854565
6. T. Neumann S. Esser A. Potthoff, et al. 2007 HIV-HEART Study Investigative Group. Prevalence and natural history of heart failure in outpatient HIV-infected subjects: rationale and design of the HIV-HEART study Eur J Med Res 12 243 248 17666313
7. T. Buck O.A. Breithardt L. Faber, et al. 2009 Manual zur Indikation und Durchführung der Echokardiographie Clin Res Cardiol 4 Suppl1 3 51
8. A. Vahanian H. Baumgartner J. Bax, et al. 2007 Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology, ESC Committee for Practice Guidelines. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology Eur Heart J 28 230 268 17259184
9. R.M. Donovan C.E. Bush N.P. Markowitz, et al. 1996 Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons J Infect Dis 174 401 403 1:STN:280:DyaK28zhtlShsw%3D%3D 8699074
10. S. Jurriaans B. Van Gemen G.J. Weverling, et al. 1994 The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course? Virology 204 223 233 10.1006/viro.1994.1526 1:STN:280:DyaK2cznvVCqtA%3D%3D 7916514 (Pubitemid 24305334)
11. B.P. Griffith H. Brett-Smith G. Kim, et al. 1996 Effect of stavudine on human immunodeficiency virus type 1 virus load as measured by quantitative mononuclear cell culture, plasma RNA, and immune complex-dissociated antigenemia J Infect Dis 173 1252 1255 1:CAS:528:DyaK28XjtVWqt7Y%3D 8627080
12. 4 count as prognostic markers and surrogate end points: a meta-analysis AIDS Res Hum Retroviruses 16 1123 1133 10.1089/088922200414965 (Pubitemid 30637014)
13. T. Reichlin W. Hochholzer S. Bassetti, et al. 2009 Early diagnosis of myocardial infarction with sensitive cardiac troponin assays N Engl J Med 361 858 867 10.1056/NEJMoa0900428 1:CAS:528:DC%2BD1MXhtVKhtL%2FP 19710484
14. G.M. Felker V. Hasselblad A.F. Hernandez, et al. 2009 Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials Am Heart J 158 422 430 10.1016/j.ahj.2009.06.018 1:CAS:528: DC%2BD1MXhtVegs7fP 19699866
15. F.C. Frerichs K.P. Dingemans K. Brinkman 2002 Cardiomyopathy with mitochondrial damage associated with nucleoside reverse-transcriptase inhibitors N Engl J Med 347 1895 1896 10.1056/NEJM200212053472320 12466522 (Pubitemid 35417789)
16. G. Simonneau N. Galiè L.J. Rubin, et al. 2004 Clinical classification of pulmonary hypertension J Am Coll Cardiol 43 SupplS 5S 12S 10.1016/j.jacc.2004.02.037 15194173 (Pubitemid 38759712)
17. U.S. Kristoffersen A.M. Lebech J. Gerstoft, et al. 2008 Right and left cardiac function in HIV-infected patients investigated using radionuclide ventriculography and brain natriuretic peptide: a 5-year follow-up study HIV Med 9 180 186 10.1111/j.1468-1293.2007.00531.x 1:STN:280:DC%2BD1c3jvFWltw%3D%3D 18218002 (Pubitemid 351279574)
18. F. Breuckmann K. Nassenstein J. Kondratieva, et al. 2007 German Heart Failure Network, Competence Network HIV/AIDS. MR characterization of cardiac abnormalities in HIV+ individuals with increased BNP levels Eur J Med Res 12 185 190 1:CAS:528:DC%2BD2sXptVSgsbs%3D 17513188
19. R. Carrillo-Jimenez T.L. Treadwell H. Goldfine, et al. 2002 Brain natriuretic peptide and HIV-related cardiomyopathy AIDS Read 11 501 503